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A versatile, high through-put, 
bead-based phagocytosis assay for 
Plasmodium falciparum
Yukie M. Lloyd1, Elise P. Ngati1, Ali Salanti2,3, Rose G. F. Leke4 & Diane W. Taylor1
Antibody-mediated phagocytosis is an important immune effector mechanism against Plasmodium 
falciparum-infected erythrocytes (IE); however, current phagocytosis assays use IE collected from infected 
individuals or from in vitro cultures of P. falciparum, making them prone to high variation. A simple, high-
throughput flow cytometric assay was developed that uses THP-1 cells and fluorescent beads covalently-
coupled with the malarial antigen VAR2CSA. The assay is highly repeatable, provides both the overall 
percent phagocytosis and semi-quantitates the number of antigen-coupled beads internalized.
Opsonic phagocytosis is an important host immune effector mechanism against blood- stage Plasmodium 
falciparum1–4. The intracellular parasite produces and displays a variety of variant surface antigens (VSA) 
on the surface of the infected erythrocytes and antibodies (Ab) against them help protect individuals from 
severe and symptomatic malaria5–7. Current assays for measuring Ab-mediated phagocytosis have used P. 
falciparum-infected erythrocytes (IE) collected from infected individuals or from in vitro cultures of P. falciparum 
that express a variety of VSA. Because of this variation, it is difficult to determine which VSA are important in 
phagocytosis, to repeat experiments, and to interpret results. Data support that members of the P. falciparum 
erythrocyte membrane protein 1 (PfEMP1) family are the key targets of naturally-acquired Ab and Ab-mediated 
phagocytosis of IE1. Thus, we sought to adapt a previously reported high-throughput phagocytosis assay that 
has proven useful in studies of bacteria8 and viruses9, to measure PfEMP1 Ab-mediated phagocytosis using the 
PfEMP1 antigen VAR2CSA to establish proof of concept. VAR2CSA causes IE to cytoadhere to chondroitin sul-
fate A on placental cells, thus only pregnant women, or women who have been pregnant, have high level of Ab to 
VAR2CSA10–12.
We sought to develop an assay that was high-throughput, highly versatile, reproducible, and could be used in 
any basic laboratory equipped with a simple flow cytometer. The steps in the assay include: 1) covalent coupling 
of recombinant P. falciparum proteins to fluorescent, carboxylated beads, 2) incubating the beads with plasma, 
3) combining the opsonized beads with THP-1 monocyte cells, and 4) determining the percentage of mono-
cytes that have internalized the beads by flow cytometry. Results showed that the assay meets our requirements 
and not only provides data on percent phagocytosis, but also gives semi-quantitative data on the number of 
antigen-coated beads internalized.
Results and Discussion
During assay development, SPHEROTM Carboxyl Fluorescent Particles, Yellow, Low-Intensity (CFL-5052-2, 
Spherotech, Lake Forest, IL) with a 5.0–5.9 μm diameter were selected, as they give a recordable fluorescent signal 
and are approximately the size of human erythrocytes. The beads were covalently coupled to full-length recom-
binant VAR2CSA using carbodiimide derivatives, EDC and Sulfo-NHS, and a protocol employed in multiplex 
bead-based LUMINEX assays13. Archival, de-identified plasma samples were used as the source of Ab. The samples 
were collected at delivery from Cameroonian women and pre-screened to determine the level of IgG to VAR2CSA. 
Plasma samples with high, intermediate, and low levels of IgG to VAR2CSA were tested. The assay was optimized 
using undifferentiated THP-1 cells, that only express CD64 (FcγR I), CD32 (FcγR II), and not CD16 (FcγR III) 
and CD362. THP-1 monocytes were maintained below 5 × 105 cells per ml of culture to ensure consistent surface 
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receptor expression. Prior to use, THP-1 cells were immuno-stained for the above receptors to confirm their surface 
phenotype (Supplementary Fig. S1). The viability of THP-1 cells was >98% at the beginning of the assay (Bio Rad 
TC20 cell counter) and >98% at the time of data acquisition (7-AAD viability dye, eBioscience).
The first step in assay optimization was to determine the optimal dilution of plasma to use (Fig. 1a). Two 
positive controls were used, including beads coupled with purified human IgG and VAR2CSA-coupled beads 
incubated with pooled plasma from multigravida women with high IgG levels to VAR2CSA. VAR2CSA-coupled 
beads incubated with plasma from nulligravid women (NG), who have Ab to multiple P. falciparum PfEMP1/
VSA, but not VAR2CSA, were used as the negative control. Percent phagocytosis was >50% for the PC and 10% 
for NG. The titration of plasma from 1:100 to 1:3,200 using PBS from 10 women showed that the percentage of 
THP-1 cells that internalized VAR2CSA-coupled beads declined with increasing plasma dilution (Fig. 1a); con-
firming a relationship between amount of IgG Ab to VAR2CSA in plasma and phagocytic activity. Using plasma 
dilutions of 1:10 and 1:50 did not increase phagocytosis. Although the highest percent phagocytosis was obtained 
at a 1:100 dilution, plasma dilutions that gave the best discrimination among the samples were 1:400 to 1:800. In a 
follow-up study using plasma from 50 Cameroonian multigravid women who had Ab to VAR2CA, a good corre-
lation between their anti-VAR2CSA Ab levels and percent phagocytosis was found, r = 0.6855, p < .0001 (Fig. 1b). 
Additional studies confirmed that phagocytosis was mediated by Abs to VAR2CSA using several specificity con-
trols, e.g., incubating THP-1 cells with VAR2CSA-coupled beads treated with plasma from Cameroonian male 
(who have Ab to multiple VSA, but not VAR2CSA) and US pregnant women, as well as, with beads coupled 
to an irrelevant antigen, keyhole limpet hemocyanin (KLH; G-Biosciences) (Supplementary Fig. S2). Finally, 
time-lapse microscopy verified that THP-1 cells selectively phagocytized opsonized VAR2CSA-coupled beads 
and not KLH-coupled beads (Supplementary Fig. S3). Similar results were obtained after reversing the coupling, 
showing that THP-1 cells did not favour one bead type (colour) over another.
Next, the new bead-based assay was compared with other standard assays used in the field. First, it was com-
pared with a standard phagocytic assay that uses IE obtained from in vitro cultures14. In the assay, CS2 P. falci-
parum IE (expressing VAR2CSA) were obtained from in vitro cultures, enriched by 0.7% gelatin flotation, stained 
with the nucleic dye dihydroethidium (DHE) and the cytosolic dye Cell Trace (Invitrogen, Waltham, MA), and 
incubated with THP-1 cells prior to analysis by flow cytometry15. Results from the two assays were significantly 
correlated (r = 0.70, p < 0.0001), with a higher percent phagocytosis found for many samples in the bead-based 
assay (Fig. 1c). It is possible the density of VAR2CSA is higher on the surface of beads compared to IE, thereby, 
enhancing sensitivity. Next, day-to-day variation of the new and standard phagocytosis assays was compared 
(Fig. 1d,e). Higher variation was found in the assay using IE (r = 0.67, p < 0.0001) than with the bead-based 
method (r = 0.96, p < .0001). Finally, the bead-based phagocytic assays was compared with the traditional cell 
surface staining assay using CS2 trophozoite-enriched IE labeled with a nucleic acid stain and then incubated 
with plasma, followed by FITC-Goat-anti-human IgG16 (Supplementary Fig. S4). A strong correlation between 
the two assay results was observed (r = 0.69, p = 0.0003). Thus, the new assay compared well with, and was signif-
icantly easier and more reproducible than, assays that are currently being used.
In the optimized assay, antigen-coupled fluorescent beads within the THP-1 cells were detected in the FL-2 
channel paired with the FL-4 channel and data were recorded as median fluorescence intensity (MFI) (Fig. 2). 
Four distinctive cell populations were seen, namely, THP-1 that had not internalized beads and three populations 
that had (Fig. 2). The three major phagocytic populations were sorted using FACS Aria and results showed the 
THP-1 cells in the peaks had internalized one, 2–3, or more than 5 VAR2CSA-coupled beads, respectively. Thus, 
the assay not only identified the percentage of THP-1 cells that phagocytized opsonized VAR2CSA-coupled beads 
(requires a single laser, FL2), but by setting parameters on a second channel (FL4), also semi-quantitated the 
number of opsonized beads phagocytized.
In conclusion, the bead-based assay for measuring Fcγ-mediated phagocytosis has advantages over assays 
using intact IE, namely, fluorescent beads are inexpensive ($0.07 USD per sample), the coupled-beads require 
minimal antigen (200 ng/106 beads), and the beads are stable for a long period of time; the assay requires neither 
in vitro cultured parasites that are expensive to grow nor purified IE that lead to inter-assay variation. The use of 
THP-1 cells maintained under standard conditions is a good source of well-characterized phagocytes. One disad-
vantage is that only one antigen, and not the whole plethora of VSA is studied, although several different PfEMP1 
proteins can be coupled to the same bead type.
A strength of the assay is its versatility. By coupling different recombinant VSA proteins, the repertoire of 
naturally-acquired Ab can be determined, both for different antigens and different domains. The new assay has 
many additional uses, e.g., antigen-competition assays using beads in distinct fluorescent spectra coupled to 
different antigens; measuring Ab-mediated phagocytosis against liver stage (e.g., LSA1), merozoite (e.g., MSP1), 
and sexual stage (e.g., Pf25) antigens by simply coupling stage-specific antigens to beads; and studies of P. vivax 
that does not grow in continuous culture. Recently, Osier et al. reported that opsonic phagocytosis of P. falci-
parum merozoites correlated with protection in children and suggested that Ab to MSP2 and MSP3 were impor-
tant. Instead of isolating merozoites, MSP2 and MSP3 could be coupled to beads and a high through-put study 
conducted to confirm and extend these interesting results. Thus, the new bead-based assay has the potential for 
becoming an important new tool in malaria research.
Methods
Ethical approval. This study was approved by the Institutional Review Board (IRB) at the University of 
Hawaii at Manoa (protocol CHS# 22325). The archival plasma samples used in the study were collected between 
1996 and 2001 in a study approved by the Ethics Committee, Ministry of Health, Cameroon and the IRB, 
Georgetown University. At the time of sample collection, written informed consent was obtained from all partic-
ipants. All experiments were performed in accordance with relevant guidelines and regulations.
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Figure 1. Detection of FcγR-mediated phagocytosis of VAR2CSA-coupled fluorescent beads. (a) The percent of 
THP-1 cells that internalized beads treated with serial dilution of the positive control (PC) (red line) consisting 
of pooled plasma from multigravida women known to have high IgG levels to VAR2CSA and the negative 
control (NG) (blue line) consisting of pooled plasma from nulligravidae who have Ab to multiple PfEMP1 
antigens, but not to VAR2CSA. The purple cross (+) represents percent phagocytosis of beads coupled with 
human IgG. (b) Percent phagocytosis of VAR2CSA-coupled beads incubated with serial dilution of plasma 
from 10 women with different levels of Ab to VAR2CSA. Figure 1a and b show representative results from 
replicate experiments. (c) Correlation between the percentage of THP-1 cells that internalized beads coupled 
with VAR2CSA (Y-axis) versus corresponding anti-VAR2CSA antibody levels measured in median fluorescent 
Intensity (MFI) units (X-axis) (n = 57). (d) Comparison of percent phagocytosis of VAR2CSA-coupled beads 
(Y-axis) and IE (X-axis) (n = 50). (e) Comparison of day-to-day variation of phagocytosis of IE (n = 31). (f) 
Comparison of day-to-day variation of phagocytosis of VAR2CSA-coupled beads (n = 31). Correlations were 
determined by Pearson’s correlation coefficient. P-values of < 0.05 were considered significant.
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Study samples. The archival, de-identified plasma samples used were collected at delivery from 
Cameroonian women residing in Yaoundé, Cameroon. Details of the study have been described17. Plasma from 
sympatric males and nulligravid women were used as negative controls, as well as plasma samples from US preg-
nant women who had not be exposed to malaria (obtained from the University of Hawaii Biorepository). All 
plasma samples were heat-inactivated for 30 minutes at 56 °C before use to inhibit complement activity.
Measuring antibody levels to VAR2CSA antigens. Plasma samples from pregnant women were 
screened for IgG to VAR2CSA using a multiplex anayte-platform (MAP) assay that has been described pre-
viously13,18. In brief, full-length recombinant VAR2CSA (FCR3 line) was covalently-coupled to MAGPLEX 
beads using saturating amounts of VAR2CSA. Then, 2000 antigen-coupled beads were incubated with 30 μl 
of plasma diluted 1:200 using PBS for 1 hour at room temperature. The beads were then washed twice with 
PBS with 0.05% Tween, once with PBS with 1% bovine serum albumin and incubated with 100 μl of 2 μg/ml 
phycoerythrin-conjugated goat anti-human IgG (Jackson ImmunoResearch) for 1 h. The beads were washed 
twice with PBS with 0.05% Tween, once with PBS with 1% bovine serum albumin, and the level of fluorescence 
was measured using a LiquiChip 200 analyzer (Luminex Corp.) programmed to analyze a minimum of 100 beads 
per spectral address, DD Gate 7500–15000. Results were expressed in MFI units.
In vitro culturing of P. falciparum IE and isolation of trophozoites. The CS2 line of P. falciparum, 
that constituently expresses VAR2CSA, was cultured in vitro in human type O-positive erythrocytes at 5% hae-
matocrit. Parasite cultures were maintained in a humidified incubator (2% O2, 8% CO2, balance N2) at 37 °C. 
Medium was replaced daily. The IE were synchronized every week using 40–80% Percoll (Sigma) density gra-
dient centrifugation19. Cultures were routinely tested by PCR for mycoplasma using the e-MycoTM Mycoplasma 
PCR Detection Kit. For the erythrocyte surface binding assay, trophozoite-stage IE were enriched to 80–90% 
using magnetic columns16,20. For the phagocytosis assays, trophozoite-stage IE were enriched using a 0.7% gela-
tin (Porcein Gelatin A, Sigma) cushion dissolved in Roswell Park Memorial Institute (RPMI) medium 1640 for 
45 minutes at 37 °C19. Trophozoite-stage IE were isolated by collecting the “funnel cloud” above the gelatin gradi-
ent, providing 40–50% trophozoite-stage IE.
IE Surface binding. Binding of IgGs to CS2-IE was measured by flow cytometry16. Enriched, 
trophozoite-stage IE were incubated with the nucleic stain Syto61 (150 µl per 3 million cells, diluted 1:2,500 with 
PBS, Invitrogen) for 15 minutes in the dark at room temperature. IE were washed three-times with PBS and then 
Figure 2. Sorting of the four major peaks by fluorescent intensity. THP-1 cells were incubated with VAR2CSA-
coupled fluorescent beads opsonized with pooled plasma from multigravid women with high levels of Ab to 
VAR2CSA. THP-1 cells were gated on FSC and SSC and then fluorescence was detected in channels FL2 and 
FL4. Four fractions were seen: THP-1 cells that did not internalize beads (black box) and 3 peaks of THP-1 cells 
that had phagocytosed fluorescent beads (coloured boxes). The photomicrographs show representative THP-1 
cells in each fraction. Table reports the percentage of THP-1 cells that had internalized different numbers of 
beads in the fractions after incubation with a pool of plasma from multigravid women. Data in the Table are 
based on sorted cells in wet-mount preparations visualize microscopy (n = 17 to 69 cells counted per fraction).
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50 µl containing 5 × 105 IE was added to V-bottom microtiter wells. The plasma used in the study was heat inacti-
vated and pre-adsorbed twice with normal erythrocytes before use. The IE were incubated with 5 µl of plasma, at 
a dilution of 1:10 with PBS for 30 minutes at room temperature. Following incubation, IE were washed three times 
with PBS with 1%BSA and then incubated with 100 µl of 1.5 mg/ml FITC-labeled, goat Fab’2 fragment anti-human 
IgG gamma specific Ab diluted at 1:800 (Invitrogen) for 30 minutes at 4 °C. Samples were washed three times 
with PBS, fixed with 200 µl of 2% paraformaldehyde in PBS and immediately analyzed by flow cytometry (FACS 
Calibur, BD Biosciences). Erythrocytes were initially gated using forward scatter (FSC) and side scatter (SSC) 
density plots (CELL Quest software, BD Biosciences). Then, IE were gated for the Syto61 fluorescence signal. A 
minimum of 10,000 IE were acquired. Surface staining was measured as the geometric median fluorescence inten-
sity (gMFI) for the IE population and the gMFI of uninfected erythrocytes was subtracted. Data were analyzed 
using the FlowJo (ver 10.6.0) software. The 3D7 strain of in vitro cultured P. falciparum parasites was used as a 
specificity control to assess the binding of Ab to non-VAR2CSA proteins expressed on the surface of IE.
THP-1 culture. THP-1 cells (ATCC), a human monocyte cell line, were maintained in RPMI 1640 
medium (GIBCO) supplemented with 10% heat-inactivated Foetal Bovine Serum (FBS, HyClone), 1% 
penicillin-streptomycin (GIBCO), 1% L-Glutamine (GIBCO), and 0.05 mM 2-Mercaptho-Ethanol (2ME, Sigma) 
at 37 °C in a 5% CO2 incubator. Cell densities were kept below 5 × 105 per ml to maintain consistent cell surface 
expression of Fc receptors (FcγRs). Prior to use, cell surface receptor expression of CD64/FcγRI (Anti-Human 
CD64 PE, Clone 10.1), CD32/ FcγRII (Anti-Human CD32 FITC, Clone 6C4), and CD16/FcγRIII (Anti-Human 
CD16 PE, Clone eBioC316) were determined by flow cytometry using FITC or PE-labeled anti-human Ab to 
these receptors (eBioscience). The day before each experiment, culture medium was changed. Only cultures with 
>98% viability were used in the phagocytosis assays. Cultures of THP-1 were also routinely tested for myco-
plasma as described above.
In vitro IE Phagocytosis Assay. Gelatin-enriched, trophozoite-stage IE (up to 20 × 106 total) were incu-
bated with 1 ml of 5 μg/ml of dihydroethidium (DHE; Molecular Probes, Life Technologies) and 1 μM of Cell 
TraceTM Far Red (Molecular Probes, Life Technologies) for 20 minutes in the dark. Cells were washed twice 
with RPMI with 2% FBS, and 1 × 106 of stained IE were aliquoted into 96-well V-bottom wells (Corning) and 
incubated with 30 μl of various dilutions of heat-inactivated plasma. The plates were incubated for 1 hour on a 
Barnstead Lab-line titer plate shaker (Model #4625, Melrose, IL) at speed 3. Subsequently, IEs were washed twice 
with 200 μl of RPMI with 2% FBS and incubated with 50 μl of 1 × 105 THP-1 cells (IE-to-monocyte ratio of 10:1) 
for 45 minutes in a 37 °C incubator (5% CO2). Following incubation, the 96-well plates were immediately placed 
on ice and 200 μl of ice-chilled PBS was added to each well to stop phagocytosis. THP-1 cells were promptly 
analyzed by flow cytometry (FACS Calibur, BD Biosciences) and gated by size and granularity on FSC and SSC 
plots (CELL Quest software, BD Biosciences). Data for at least 3,000 THP-1 cells were recorded for each sample. 
Data were analyzed using the FlowJo (ver 10.6.0) software. The percent phagocytosis equals the proportion of 
THP-1 cells that were positive for DHE and Cell Trace staining. Additional controls for the IE phagocytosis assays 
included: 1) non-opsonized IE; and 2) opsonized IE incubated with THP-1 at 4 °C.
Coupling of fluorescent beads to P. falciparum antigen. One million yellow, carboxylated, fluorescent 
beads (CFL-5052-2; 5.0-5.9 μm, Spherotech) were covalently coupled with 200 ng of VAR2CSA or keyhole limpet 
hemocyanin (KLH; 200ng/million beads) using the carbodiimide reaction13. Beads were resuspended by vortexing 
and sonicating for 20 seconds before transfer to a microfuge tube. Beads were then pelleted by micro-centrifugation 
at 18,000 × g for 2 minutes. Supernatant was removed, beads were resuspended in 100 µl of ddH2O by vor-
texing and sonication for 20 seconds. Beads were again pelleted at 18,000 × g for 2 minutes and the superna-
tant was replaced with 80 µl of activation buffer (0.1 M NaH2PO4, pH 6.2). Ten microliters of freshly-prepared 
Sulfo-N-hyroxysulfosuccinimide (Sulfo-NHS) and 10 µl of 1-ethyl 3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC; Pierce) solutions (10 mg into 200 µl of ddH2O) were added to each tube, gently mixed by 
vortexing, and incubated for 20 minutes in the dark, with gentle mixing by vortexing every 10 minutes. Activated 
beads were pelleted, supernatant was removed and beads were resuspended in 100 µl of coupling buffer (0.05 M 
MES, pH 7.0) by vortexing and sonicating for 20 seconds. After two washes with the coupling buffer, beads were 
resuspended in 100 µl of coupling buffer, vortexed and sonicated, and an optimal amount of antigen was added. The 
coupling reaction was mixed by votexing only and incubated at room temperature for 4 hours or at 4 °C overnight 
on a plate shaker at speed 6. Following incubation, coupled beads were pelleted at 18,000 × g for 2 minutes and 
supernatant was replaced with 1 ml of blocking/storage buffer (50 ml PBS-1%BSA, 10 µl Tween 20, 25 mg or 125 µl 
of a 20% solution Sodium Azide). A total of two washes was performed. Coupled beads were finally resuspended 
in blocking/storage buffer at 25,000 beads/µl and stored in the dark at 4 °C until used.
In vitro Bead Phagocytosis Assay. First, 100,000 VAR2CSA-coupled beads were incubated with diluted, 
heat-inactivated plasma in a sterile 96-well V-bottom plate (Corning) at a total volume of 30 μl. The plate was 
covered with foil to prevent fluorescent beads from photobleaching and the plate was placed on a plate shaker 
at speed 5 for 1 h. Following two washes with PBS, beads were incubated with RPMI 50 μl containing 2 × 104 
THP-1 cells (beads-to-monocyte ratio of 5:1) for 45 minutes in a 37 °C incubator (5% v/v CO2). Then, the 96-well 
plates were placed on ice and 200 μl of chilled PBS was added to each well to stop phagocytosis. Samples were 
immediately read on FACS Calibur (BD Biosciences). THP-1 cells were gated by size and granularity on FSC 
and SSC plots (CELL Quest software, BD Biosciences). Data for at least 3,000 THP-1 cells, or at least 15% of 
total THP-1 cells in the well, were recorded for each sample. Data were analyzed using the FlowJo (ver 10.6.0) 
software. Percent phagocytosis was the proportion of THP-1 cells that were positive for fluorescence in the FL-2 
channel. THP-1 cells in three major fluorescence peaks were visualized by setting the FL-2 channel against the 
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 14705  | DOI:10.1038/s41598-017-13900-4
FL-4 channel. To determine the cellular contents of the three peaks, the peaks were sorted using a FACS Aria (BD 
Biosciences). Each of the peaks was examined using wet-mount microscopy and the number of THP-1 cells that 
had engulfed 0, 1, 2, 3, 4+ fluorescence beads were tallied by two researchers. Photomicrographs of representative 
fields were taken using a 3.3MPX Digital Microscope Camera (ImagingPlanet, Santa Barbara, CA).
Time-lapse Fluorescence Microscopy. For the video of the time-lapse fluorescent microscopy of phago-
cytosis, 2 × 104 or 1 × 105 THP-1 cells were plated into flat-bottom, polylysine-coated, 96-well plates (LabTek, 
MatTek). Then, 100,000 or 500,000 yellow or nile blue (CFL-5065-2; 5.0-5.9μm, Spherotech) fluorescent beads 
coupled with VAR2CSA or KLH were added to the adherent THP-1 cells. Phagocytosis was immediately imaged 
using an automated IX-81 microscope (Olympus, Japan) with a WSKM stage top incubator (Tokai Hit, Japan) 
that kept the cells at 37 °C and 5% CO2. Cells were imaged at a magnification of 320X every 30 seconds for 1 hour. 
For each time point, three images were taken in sequence, one for bright field, one using a GFP filter set, and 
one using a TxRed filter set. All images were captured using an Orca-R2 C10600 camera (Hamamatsu, Japan) 
controlled by Metamorph v.7.8.1 software (Molecular Devices, Downington, PA) which combined the images 
collected every 30 seconds into the video.
Statistical Data Analysis. Data analyses was performed using Microsoft Excel and Prism version 7.03 
(Graph Pad Software Inc.). Correlations were examined by Pearson’s Correlation Coefficient. P-values of < 0.05 
were considered statistically significant.
References
 1. Keen, J. et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med 4, e181, https://doi.
org/10.1371/journal.pmed.0040181 (2007).
 2. Ataide, R. et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated 
malaria. PLoS One 5, e10807, https://doi.org/10.1371/journal.pone.0010807 (2010).
 3. Ataide, R., Mwapasa, V., Molyneux, M. E., Meshnick, S. R. & Rogerson, S. J. Antibodies that induce phagocytosis of malaria infected 
erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS One 6, e22491, https://doi.org/10.1371/journal.
pone.0022491 (2011).
 4. Osier, F. H. et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of 
protection against malaria. BMC Med 12, 108, https://doi.org/10.1186/1741-7015-12-108 (2014).
 5. Duffy, P. E. & Fried, M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with 
increased birth weight and the gestational age of newborns. Infect Immun 71, 6620–6623 (2003).
 6. Salanti, A. et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 200, 1197–1203, https://doi.
org/10.1084/jem.20041579 (2004).
 7. Feng, G. et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection 
from treatment failure and the development of anemia in pregnancy. J Infect Dis 200, 299–306, https://doi.org/10.1086/599841 
(2009).
 8. Steinberg, B. E., Scott, C. C. & Grinstein, S. High-throughput assays of phagocytosis, phagosome maturation, and bacterial invasion. 
Am J Physiol Cell Physiol 292, C945–952, https://doi.org/10.1152/ajpcell.00358.2006 (2007).
 9. Ackerman, M. E. et al. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. J Immunol 
Methods 366, 8–19, https://doi.org/10.1016/j.jim.2010.12.016 (2011).
 10. Fried, M. & Duffy, P. E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272, 
1502–1504 (1996).
 11. Fried, M., Nosten, F., Brockman, A., Brabin, B. J. & Duffy, P. E. Maternal antibodies block malaria. Nature 395, 851–852, https://doi.
org/10.1038/27570 (1998).
 12. Salanti, A. et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium 
falciparum involved in pregnancy-associated malaria. Mol Microbiol 49, 179–191 (2003).
 13. Fouda, G. G. et al. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clin 
Vaccine Immunol 13, 1307–1313, https://doi.org/10.1128/CVI.00183-06 (2006).
 14. Teo, A., Hasang, W., Boeuf, P. & Rogerson, S. A Robust Phagocytosis Assay to Evaluate the Opsonic Activity of Antibodies against 
Plasmodium falciparum-Infected Erythrocytes. Methods Mol Biol 1325, 145–152, https://doi.org/10.1007/978-1-4939-2815-6_12 
(2015).
 15. Chan, C. L., Renia, L. & Tan, K. S. A simplifi d, sensitive phagocytic assay for malaria cultures facilitated by fl w cytometry of 
differentially-stained cell populations. PLoS One 7, e38523, https://doi.org/10.1371/journal.pone.0038523 (2012).
 16. Staalsoe, T., Giha, H. A., Dodoo, D., Theander, T. G. & Hviid, L. Detection of antibodies to variant antigens on Plasmodium 
falciparum-infected erythrocytes by flow cytometry. Cytometry 35, 329–336 (1999).
 17.  Tako, E. A. et al. Risk factors for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med 
Hyg 72, 236–242 (2005).
 18. Tutterrow, Y. L. et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental 
malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun 80, 1479–1490, https://
doi.org/10.1128/IAI.00071-12 (2012).
 19. Moll, K., Kaneko, A., Scherf, A. & Wahlgren, M. The6th Edition of Methods in Malaria Research. 6th edn (2013).
 20. Miltenyi, S., Muller, W., Weichel, W. & Radbruch, A. High gradient magnetic cell separation with MACS. Cytometry 11, 231–238, 
https://doi.org/10.1002/cyto.990110203 (1990).
Acknowledgements
We thank researchers and the laboratory staff at the Biotechnology Centre, University of Yaoundé I, Cameroon, 
for collecting, processing and archiving the samples. We thank A. Gurary, JABSOM Molecular and Cellular 
Immunology Core, for help with flow cytometry and C. Farrar, Cancer Centre Microscopy and Imaging Core 
for assistance with time-lapse microscopy. Thanks also to M. Sanchez and N. Bobbili for assistance in assay 
optimization and M. Fernandez for microphotography. NIH grants R21AI 105286 to D.W.T.; FIC training grant 
5D43TW009074 supported E.P.N., NIAID R21 AI supported Y.M.L; the Molecular and Cellular Immunology 
Core is supported by grant P30GM114737; and Microscopy and Imaging Core of the Cancer Centre is supported 
by NCI P-30 grant CA071789-15.
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 14705  | DOI:10.1038/s41598-017-13900-4
Author Contributions
Y.M.L. and D.W.T. conceived the project. Y.M.L. carried out the experiments and analyzed the data. E.P.N. ran 
the surface staining experiments. A.S. provided the recombinant proteins. R.G.F.L. supervised the collection of 
samples. Y.M.L. and D.W.T. wrote the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-017-13900-4.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
